Altaris, LLC’s Post

On the eve of our upcoming April meeting at AdvaMed - please see this timely report from our friends at the American Investment Council (AIC). With the possibility of further Rx price controls and a new regulatory push to allow entities to "march in" and seize intellectual property rights, policymakers need to have a heightened understanding of the drivers that make for a positive innovation environment for innovators. https://lnkd.in/e6xEKYQi Excerpts: "PE capital ultimately helps patients, and that assistance comes in dozens of ways. Health care quality is improved— PE sponsors help finance innovative medical devices and provide safer recoveries for patients. Affordability is improved, especially when PE sponsors help reorganize health care institutions and make them more efficient. Most importantly, PE sponsors improve health care access by helping urgent care centers expand deeper into rural America as well as helping specialized clinics like oncology and OB-GYN centers open new locations, hire more doctors and staff, and make those services available to more patients around the country." Medical Devices: "According to PitchBook, PE sponsors have invested over $125 billion into medical device manufacturers over the past decade. In the same time frame, 871 manufacturers  partnered with PE sponsors to grow their footprints, innovate their products, hire more people to make them, and ultimately distribute them to the doctors and patients who need them. PE capital is used to finance devices that can address unmet needs. Not only did these devices not exist before PE capital became involved, but the devices themselves provide life-improving benefits to patients, including more successful surgeries and shorter, less painful recovery times."

𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐓𝐡𝐞 𝐑𝐢𝐬𝐞 𝐨𝐟 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐑𝐨𝐨𝐦 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 📥 Download the PDF: https://lnkd.in/deDCPtr7 In today's fast-paced healthcare environment, efficient operating room management is more crucial than ever. As hospitals strive to optimize patient care, reduce costs, and improve outcomes, the adoption of advanced OR management solutions is becoming a game-changer. 🚀 Market Growth: The operating room management market is experiencing explosive growth. In terms of revenue, it was estimated to be worth $4.2 billion in 2024 and is poised to reach $7.5 billion by 2029, growing at a CAGR of 12.5%. Key benefits of implementing robust OR management systems: 1. 📊 Enhanced Scheduling: Minimize delays and maximize OR utilization 2. 💰 Cost Reduction: Streamline processes and resource allocation 3. 🏥 Improved Patient Safety: Better coordination leads to fewer errors 4. 📈 Increased Efficiency: Optimize workflows for faster turnaround times 5. 📱 Real-time Analytics: Make data-driven decisions on the fly As healthcare continues to evolve, investing in operating room management solutions is not just a trend—it's a necessity for hospitals aiming to stay competitive and provide top-notch patient care. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Oracle, Epic Systems Corporation (US), Medical Information Technology (Meditech) (US), GE HealthCare, Surgical Information Systems (US), Becton, Dickinson And Company (US), eClinicalWorks, PICIS CLINICAL SOLUTIONS, LTD., Brainlab, Getinge, Veradigm®, STERIS, Medovate Limited, Cardinal Health, Barco Electronic Systems Pvt Ltd (Belgium), Richard Wolf GmbH, KARL STORZ, Caresyntax, mediCAD®, UnitedHealth Group, Qventus, Inc, Alert Life Sciences Computing S.A., (Europe), Tedisel Medical (Spain), Censis Technologies (US), and Owens & Minor (US) Other Companies that are Operating in this Market Globally: Genentech Bayer Roche Boston Scientific Thermo Fisher Scientific Cleveland Clinic Mayo Clinic Life Technologies Quest Diagnostics Express Scripts by Evernorth ICON plc Queensland Health Beckman Coulter Diagnostics MD Anderson Cancer Center Providence Health & Services MedCepts Medical Sales & Marketing Network - Medical Devices / Pharmaceuticals      NewYork-Presbyterian Hospital   CareFusion Edwards Lifesciences CR Bard #HealthcareInnovation #OperatingRoomManagement #HospitalEfficiency #HealthTech

MedTech News💡 BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader! MedTech at it again! & Certainly one to keep on eye on! For me it will be interesting to see how both companies are going to be impacted by this.🧠 #medtechnews#medtech#medicaldevices

Strategic MedTech collaboration is the new norm. From Medtronic to Abbott, what's driving this shift? Is it the race to innovate faster, smarter, and together? Or access to a bigger customer base, leading to a bigger piece of the pie? Medtronic and Abbott teaming up on diabetes solutions… Karl Storz & Fujifilm revolutionizing GI endoscopy… Think Surgical joining forces with Zimmer Biomet and Medacta… the list goes on! These partnerships aren't just about sharing resources – they’re about shaping the future of healthcare. Sure, this gives them access to each other’s customer base and helps keep the shareholders happy. But major challenges in our field, like access to care and affordability, can only be addressed on a larger scale and in a shorter time through these collaborations. As companies leverage each other's strengths, they not only push technological boundaries but also provide better care options for patients worldwide. What other partnerships do you think could transform healthcare?

🚀 Exciting News in Medical Diagnostics! 🚀 In a landmark collaboration, Bosch Healthcare Solutions GmbH and Randox are spearheading a transformative investment in the Vivalytic analysis platform, ushering in a new era of precision diagnostics and healthcare efficacy. As Stefan Hartung, chairman of the Bosch board of management, aptly puts it, "With cutting-edge technology from our own labs and our own production lines, we want to grow long-term together with partners in the field of precision diagnostics." The strategic partnership aims to revolutionize medical diagnostics by providing fast and highly precise analysis at the point of care. According to Marc Meier, managing director of Bosch Healthcare Solutions GmbH, "Globally, healthcare is moving toward decentralized and personalized diagnostics, that enable rapid interventions and individual treatment plans." The collaboration signifies a commitment to innovation and shared growth. As Dr. Peter Fitzgerald, Managing Director of Randox Laboratories Ltd., emphasizes, "Randox has always been committed to improving health worldwide and sees the need to invest in research and development initiatives that will support clinical decision making across a variety of disease areas." Together, Bosch and Randox aim to pioneer the next generation of medical technology, leveraging their combined expertise and global networks. Join us in this journey of innovation and shared growth, as we make a tangible difference in healthcare worldwide. https://lnkd.in/e-gJgYiM Follow Practical Patient Care for Daily Healthcare News Updates and our Weekly Newsletter Subscription! #PracticalPatientCare #MedicalTechnology #Innovation #HealthcareRevolution

In a strategic move to bolster the #medicaltechnology (MedTech Corporation) landscape, Cyient has officially joined forces with the Massachusetts Medical Device Industry Council (MassMEDIC ), a prominent regional MedTech Corporation association based in the United States. The #collaboration is poised to reinforce the MedTech Corporation community by elevating standards in product development, testing, and compliance with stringent #regulatory measures. Anand Parameswaran, President and Business Head of #Healthcare & Life Sciences at Cyient, expressed the significance of this partnership, stating, “Joining MassMedic marks a significant milestone in our journey toward becoming a key enabler in the medtech industry. Our goal is to leverage our deep domain knowledge and digital expertise to accelerate innovation, improve patient outcomes, and reduce healthcare costs.” As part of this #collaborative endeavor, Cyient and MassMEDIC will roll out a series of initiatives designed to tackle #critical challenges in the medtech sector. These initiatives will encompass #collaborative workshops, thought leadership sessions, and innovation-driven projects. The aim is to foster technological advancements and facilitate knowledge sharing among industry leaders. Rachel Robinson, Chief Operating Officer of MassMedic, warmly welcomed Cyient’s membership, emphasizing, “Cyient’s engineering excellence and commitment to innovation make them a valuable addition to our association. Together, we look forward to driving significant advancements in the medtech space.” Anticipated to yield substantial benefits for the MedTech Corporation community, this partnership is poised to enhance the development and deployment of cutting-edge medical technologies, ultimately contributing to improved health outcomes on a global scale. #News #Medlr #Healthnews #Healthcare #Health

Collaboration between the medical device industry and physicians is key to developing breakthrough interventional therapies    Developing a #MedicalDevice demands a synergy of innovation and clinical insight, underscoring the indispensable collaboration between industry and physicians. This partnership is the cornerstone of creating devices that not only push the boundaries of technology but also seamlessly integrate into clinical practice to enhance patient outcomes. The medical device industry plays a crucial role in advancing healthcare by transforming physician ideas into viable therapies. This process involves extensive research and development, ensuring that new devices are innovative and superior to existing technologies. A significant challenge in this regard is the testing phase, which must be feasible and closely aligned with actual clinical scenarios. This is where #simulation proves to be extremely valuable. It provides realistic and repeatable testing environments that mirror human anatomy and procedural complexities, replicating device performance and behavior. Communication and early feedback from key opinion leaders are essential ingredients for a successful product design and validation process. By offering a common platform for testing and feedback, simulation can enhance this collaboration and facilitate the development process. Dive into the insightful article by Fred Gunderman, Senior VP USA at Balt, on the challenges facing the #MedTech industry when developing interventional therapies: https://ow.ly/iyj550SpUE2

Mainstay Medical, creator of a groundbreaking neurostimulation therapy for lower back pain, received a major vote of confidence as investors put together a $125 million equity financing deal. “A financing of this magnitude will allow us to accelerate our efforts to revolutionize the treatment of mechanical low back pain through ReActiv8 Restorative Neurostimulation, including by continuing our rapid commercial growth and building on our insurance coverage for ReActiv8,” said Jason Hannon, CEO of Mainstay Medical. The financing was co-led by Gilde Healthcare and Viking Global Investors, with the participation from Sofinnova Partners through its Crossover Strategy, Ally Bridge Group, Fountain Healthcare Partners, and PERCEPTIVE LIFE SCIENCES FUND L P. ReActiv8 is an implantable medical device designed to treat adults with intractable chronic low back pain (CLBP) associated with multifidus muscle dysfunction. ReActiv8 has received regulatory approval in several geographic areas, and is commercially available in the European Economic Area, Australia, the UK, and the US. Read more: https://hubs.ly/Q02mlkT_0 Cédric Moreau Claire Catherinet, PhD Medtronic Latham & Watkins Perceptive Advisors Matt Onaitis LifeSci Advisors, LLC Brian Ritchie FTI Consulting Jonathan Neilan #innovation #biotech #chroniclowbackpain #mainstaymedical #SofinnovaPartners #VentureCapital

Happy #groundhogday - What's new in #woundcare and #limbpreservation this week? RTI Surgical® is acquiring Cook Biotech – no news on the financial details of the transaction, but positions this as a strategy to increase their ability to develop both allograft and xenograft technologies at scale, as a CDMO it provides clear capabilities advancements. 📈 Earnings 📈 Essity – Full year 2023 of Health and Medical sales up 12.2% ($2.6B), growth in Q4 was ~6% and largely driven through a price/mix shift. Next Science – full year 2023 revenue of $22M, up almost 90% YoY. Attributed Q4 to strong wound care DME sales and growth in VA and LTC. 📢 News 📢 MolecuLight – awarded federal contract - The US Department of Veterans Affairs has awarded MolecuLight Corp. a Federal Supply Contract for its wound imaging devices that detect harmful bacteria, allowing clinicians to make real-time, bedside decisions for treatment. Celularity Inc. – Been busy in New Jersey!! Closed two financing rounds totaling $21M, the resignation of Robin L. Smith as a board member, guidance for full-year 2023 ~$22M, but wait – guidance for the full year 2024 of ~$50-$56M (that's some forecasted growth!!). Imbed Biosciences Inc. – awarded a woundcare agreement with Premier via a technology breakthrough designation for Pelashield. MiMedx – I recently covered a LOT of activity going on with them, but that ever-present fact that they are majority held by institutional investors… well, a law firm is investigating claims “on behalf of” investors, related to the warning letter. Likely to drive the price down, to buy more shares. Perceptive Solutions – Introduced the WoundZoom Pro demonstrating continued growth of shifts onto more accessible smartphone platforms and expansion of #ai Even "quiet" weeks - have consistent activity in this space. Now to see if #punxsutawney phil has any news for us.